Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YEATS2 antisense RNA 1 (YEATS2-AS1)
- Target
- YEATS2-AS1
- Molecular classification
- Long noncoding RNA (lncRNA)
01
Overview
YEATS2 antisense RNA 1 (YEATS2-AS1) is a human long noncoding RNA gene transcribed from the opposite strand of the YEATS2 locus on chromosome 3 (chr3:183,524,245-183,528,571, reverse strand). It does not encode a protein and instead belongs to the class of long noncoding RNAs, molecules increasingly recognized as regulatory elements in various biological processes. No established literature describes YEATS2-AS1 as a therapeutic target, nor are there validated functions, disease associations, drugs, or clinical biomarkers currently associated with this gene. Most available entries simply describe its genomic position and classification as a noncoding RNA. If you were looking for the protein YEATS2 (YEATS domain containing 2), that is a well-studied histone mark reader and epigenetic regulator with established roles in cancer biology and drug discovery; YEATS2-AS1 is its antisense RNA and should not be confused with it.
- Other names
- YEATS2-AS1YEATS2 antisense RNA 1
02
Mechanism of action
Not applicable
03
Biological functions
Possible gene regulation
04
Disease associations
None established in current literature or reference databases specific to YEATS2-AS1; some expression data available, but no established disease role
05
Safety considerations
None reported
06
Interacting drugs
None known
07
Biomarkers
None known for patient selection or efficacy monitoring
Beyond the preview
Go deeper on YEATS2 antisense RNA 1 (YEATS2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YEATS2 antisense RNA 1 (YEATS2-AS1).